🎧 Listen to this article

BPC-157: The Gut-Healing Peptide Your Doctor Won’t Mention

BPC-157 is a 15-amino-acid peptide first isolated from human gastric juice. A 2023 review in Pharmaceuticals (Sikirić et al.) summarizes over 100 studies showing it consistently promotes healing in the gut, tendons, and multiple organ systems. The peptide interacts with the nitric oxide system and promotes new blood vessel formation, actively supporting tissue repair rather than masking symptoms.

Your doctor has probably never heard of it. That has nothing to do with the science and everything to do with who funds drug research.

What is BPC-157, exactly?

BPC stands for “Body Protection Compound.” It’s a pentadecapeptide — a chain of 15 amino acids — originally isolated from human gastric juice. Your body makes a version of this naturally; it’s part of how your gut protects and repairs its own lining.

The synthetic version has been studied since the 1990s by Predrag Sikirić’s team at the University of Zagreb. They’ve published more than 100 papers covering gut ulcers, tendon healing, brain protection, and organ failure. The 2023 review in Pharmaceuticals pulls together three decades of work: BPC-157 promotes healing across multiple organ systems with a consistent safety profile in every study conducted.

What does the research actually show?

Gut healing

This is where the evidence is strongest. BPC-157 promotes healing of intestinal ulcers, protects against NSAID damage (ibuprofen, aspirin, naproxen), and repairs intestinal barrier function — what people commonly call “leaky gut.”

A 2024 study in Inflammopharmacology showed BPC-157 protected against multiorgan failure caused by vascular occlusion. A 2020 review in Gut and Liver documented its cytoprotective effects — it protects cells from damage at the source.

The mechanism is specific: BPC-157 interacts with the nitric oxide (NO) system, promotes angiogenesis (new blood vessel formation), and modulates dopaminergic and serotonergic pathways. It’s not covering up symptoms. It’s actively supporting tissue repair.

Tendon and muscle healing

A 2019 review in Cell and Tissue Research found BPC-157 accelerated musculoskeletal soft tissue healing. A 2011 study in Journal of Applied Physiology showed it promoted tendon outgrowth, cell survival, and cell migration during repair.

A 2021 review in Frontiers in Pharmacology confirmed: BPC-157 consistently promotes wound healing across multiple tissue types. For anyone dealing with nagging tendon injuries or slow healing, this is the kind of research that gets your attention.

NSAID protection

NSAIDs (ibuprofen, naproxen, aspirin) are among the most commonly used drugs. They’re also one of the biggest causes of gut damage.

A 2013 study showed BPC-157 counteracted toxicity from NSAIDs across multiple organ systems. If you take ibuprofen regularly for pain or inflammation, BPC-157 may protect your gut lining from the damage those drugs cause.

Is BPC-157 proven to work in humans?

Mostly in animals. The human clinical trial data is limited, and I’d be doing you a disservice to gloss over that.

A 2025 narrative review titled “Regeneration or Risk?” put it plainly: the preclinical evidence is compelling, but human trials are still lacking. The animal studies are consistent across species, organ systems, and injury models — which is unusual and suggests the effects translate. But “suggests” is not “proves.”

We don’t have the same level of human evidence for BPC-157 that we have for omega-3s or magnesium. If that’s your bar, BPC-157 doesn’t clear it yet. If you’re comfortable with strong preclinical data and a clean safety profile, it’s worth knowing about.

Why won’t your doctor recommend it?

Three reasons, none of them scientific.

No pharma funding. BPC-157 is a naturally derived peptide. It can’t be easily patented. Without patent protection, pharmaceutical companies have no financial incentive to fund expensive human clinical trials. No trials means no FDA approval means no drug reps pushing it to doctors.

Not in medical school curricula. Doctors learn about drugs that are FDA-approved or in active clinical development. BPC-157 doesn’t fall into either category, so it’s simply not taught.

The supplement gray zone. BPC-157 exists in a regulatory gap. It’s not FDA-approved as a drug, but it’s available as a “research peptide.” Doctors are trained to recommend FDA-approved treatments, not experimental peptides purchased online.

Your doctor isn’t wrong. The system isn’t set up to surface promising compounds that can’t be monetized.

How do people actually get BPC-157?

Since it’s not available as a standard supplement, people typically access it through:

  • Research peptide vendors — sold for “research purposes only”
  • Compounding pharmacies — some doctors prescribe it this way (ask your functional medicine doctor)
  • Oral capsules — some companies sell oral BPC-157, though oral bioavailability is debated

The most common dosing protocol in the research community is 250–500 mcg taken twice daily. Some people use injectable forms for more targeted delivery.

Talk to a healthcare provider before using BPC-157, especially if you’re pregnant, nursing, or on medications. The safety profile in animal studies is clean, but human safety data is limited.

Is BPC-157 worth trying?

Over 100 published studies show consistent gut healing, tendon repair, and organ protection. The mechanism is well-understood. The safety profile in animal studies is clean.

It’s not FDA-approved. Most of the evidence is from animal studies. It exists in a regulatory gray zone that makes it invisible to mainstream medicine.

If you’re dealing with gut issues, chronic inflammation, or slow-healing injuries, BPC-157 is worth researching further — and worth discussing with a functional medicine doctor who’s familiar with peptides. The science is there. The system hasn’t caught up.

Coming soon: Which peptides actually work? A practical guide to peptide therapy for inflammation, gut health, and recovery.

Note: BPC-157 is not available as an Amazon supplement. It’s classified as a research peptide. If you’re interested in trying it, consult a functional medicine doctor who can prescribe it through a compounding pharmacy. Find a functional medicine practitioner near you.

FTC Disclosure: This article contains no affiliate links. BPC-157 is not available through standard supplement retailers. All research cited is from peer-reviewed PubMed studies.

References

  1. Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function. Pharmaceuticals. 2023;16(5):676.
  2. Sikiric P, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865.
  3. Vukojevic J, et al. Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res. 2022;17(3):482-483.
  4. Sikiric P, et al. New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. Inflammopharmacology. 2024;32(5):3027-3046.
  5. Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 and Selye’s Stress Coping Response. Gut Liver. 2020;14(2):153-167.
  6. McGuire FP, et al. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025;18(12):567-578.
  7. Sikiric P, et al. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr Pharm Des. 2013;19(1):76-83.
  8. Gwyer D, et al. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159.
  9. Seiwerth S, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021;12:627533.
  10. Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing. J Appl Physiol. 2011;110(3):774-780.